![]() | Up a level |
Shahzad, Mahnum, Naci, Huseyin, Esselen, Katharine M., Dottino, Joseph A. and Wagner, Anita K. (2024) Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway. Journal of Pharmaceutical Policy and Practice, 17 (1). ISSN 2052-3211
Shahzad, Mahnum, Naci, Huseyin and Wagner, Anita K. (2023) Association between preapproval confirmatory trial initiation and conversion to traditional approval or withdrawal in the FDA accelerated approval pathway. JAMA, 329 (9). 760 - 761. ISSN 0098-7484